Clinical risk assessment
Cisplatin-Associated Acute Kidney Injury (CP-AKI) Risk Calculator
Estimates the risk category for severe acute kidney injury after a first intravenous cisplatin treatment using the published simplified CP-AKI point score.
Patient information
Result
Simplified CP-AKI score
0
out of 22.5 pointsRisk category
—
—
Observed rate in the external validation cohort, not an individual deterministic probability.
Interpretation
Score breakdown
| Variable | Patient value | Points |
|---|
Method and limitations
This page implements the published simplified point score. The full 10-variable primary model uses nonlinear restricted cubic splines and is not reproduced here without its complete coefficient set. In the simplified score, serum creatinine and platelet count do not contribute points, while current or former smoking history is included.
Intended for qualified health professionals. Confirm units, laboratory timing, treatment context, local cisplatin protocols, and patient eligibility before use. Do not use this result as the sole reason to give, withhold, or alter cisplatin.
References
- Gupta S, et al. Derivation and validation of a prediction model for cisplatin-associated acute kidney injury. BMJ. 2024;385:e077169. View source article
- MDCalc. Cisplatin-Associated Acute Kidney Injury (CP-AKI) Risk Calculator. View clinical reference page
